Accounts Payable Disclosure [Abstract] Accounts Payable Disclosure [Text Block] Accounts Payable Accounts Payable Disclosure [Text Block] Accrued Liabilities [Abstract] Accounts Payable and Accrued Liabilities Disclosure [Text Block] Accrued Expense Accrued License Payments Related Party Abstract Collaborative and License Arrangement Disclosure [Text Block] Accrued License Payments - Related Party Collaborative and License Arrangement Disclosure [Text Block] Stockholders' Equity Note [Abstract] Stockholders Equity Note Disclosure [Text Block] Stockholders' Equity Stock Options And Warrants [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Stock Options and Warrants Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Subsequent Events [Abstract] Subsequent Events [Text Block] Subsequent Events Disclosure Organization and Business Additional Information [Abstract] Disclosure - Organization and Business - Additional Information [Abstract] Organization and Nature Of Operations [Table] Organization and Nature of Operations [Table] Legal Entity [Axis] Entity [Domain] Product Or Service [Axis] Products and Services [Domain] Phase One [Member] Phase I clinical trial Phase 1 [Member] Subsidiary, Sale Of Stock [Axis] Sale Of Stock, Name Of Transaction [Domain] Private Placement [Member] Private Placement memorandum Statement Equity Components [Axis] Equity Component [Domain] Common Stock [Member] Common Stock Warrant [Member] Warrant Warrant Range [Axis] Range [Domain] Minimum [Member] Minimum Maximum [Member] Maximum Related Party Transaction [Axis] Related Party Transaction [Domain] Sabby Investors [Member] Sabby Investors Sabby investors member Organization and Nature Of Operations [Line Items] Organization and Nature of Operations [Line Items] Organization and Nature of Operations [Line Items] Percentage Of Change In Depreciation Amortization Of Intangible Assets and Asset Impairment and Other Charges Operating Percentage of Charge Percentage of Change in Depreciation Amortization of Intangible Assets and Asset Impairment and Other Charges Operating Other Asset Impairment Charges Impairment of License Technology impairment charge Technology impairment Cash Cash Cash, beginning of period Cash, end of period Authorised Capital To Be Raised Authorized capital to be raised Represents capital value registered through shelf registration statement Stock Issued During Period Shares New Issues Stock issued during period, shares, new issues Common stock and warrants issued, shares Stock Issued During Period, Value, New Issues Stock issued during period, value, new issues Common stock issued , value Proceeds from Issuance Initial Public Offering Proceeds from issuance initial public offering Related Party Transactions [Abstract] Schedule Of Related Party Transactions By Related Party [Table] Related Party [Axis] Related Party [Domain] Md Anderson Cancer Center [Member] MD Anderson Cancer Center Md Anderson Cancer Center [Member] Income Statement Location [Axis] Income Statement Location [Domain] Research and Development Expense [Member] Research and Development Expense Nature Of Expense [Axis] Interim Period Costs Not Allocable [Domain] Clinical Trials [Member] Clinical Trials Clinical Trials [Member] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Accrued Liabilities Related Parties Current Accrued expense - related party Accrued expense - related party Accrued Liabilities, Related Parties, Current Accrued License Payments - Related Party Accrued license payments - related party Accrued license payments - related party Related Party Transaction, Expenses from Transactions with Related Party Cash paid to MD Anderson Cancer Center for expenses Accounts Payable - Related Party Accounts payable - related party Accounts payable - related party Research and Development Expense Research and Development Research and development Disclosure Prepaid Drug Product For Testing Additional Information [Abstract] Disclosure - Prepaid Drug Product for Testing - Additional Information [Abstract] Inventory Disclosure [Table] Inventory Disclosure [Table] Inventory Disclosure [Line Items] Inventory Disclosure [Line Items] Inventory Disclosure [Line Items] Other Inventory, Gross Prepaid drug product for testing Prepaid drug product for testing Other inventory, gross Statement Of Financial Position [Abstract] Statement [Table] Statement [Line Items] Assets [Abstract] ASSETS Assets Current [Abstract] Current assets Other Assets Current Other current assets Assets Current Total current assets Other Assets Noncurrent [Abstract] Other assets Finite Lived License Agreements Gross Technology licenses - related party Finite Lived Intangible Assets Accumulated Amortization Less Accumulated Amortization Intangible Assets, Net (Excluding Goodwill) Intangible Assets, Net (Excluding Goodwill), Total Assets TOTAL ASSETS Liabilities and Stockholders Equity [Abstract] LIABILITIES & SHAREHOLDERS' EQUITY Liabilities Current [Abstract] Current liabilities Accounts Payable Current Accounts payable Accrued Liabilities Current Accrued expense Liabilities Current Total current liabilities Long Term Debt Noncurrent Long term debt Liabilities TOTAL LIABILITIES Stockholders Equity [Abstract] Shareholders' Equity Preferred Stock Value Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding Common Stock Value Common Stock, $.001 par value, 200,000,000 shares authorized 89,237,872 and 84,237,872 shares issued and outstanding as of 6/30/14 and 12/31/13, respectively Additional Paid In Capital Additional paid in capital Development Stage Enterprise Deficit Accumulated During Development Stage Accumulated deficit during development stage Stockholders Equity Total shareholders' equity Liabilities and Stockholders Equity TOTAL LIABILITIES & SHAREHOLDERS' EQUITY Accounts Payable [Table] Accounts Payable Accounts payable Accounts Payable, Trade Accounts payable, trade Accounts Payable, Other, Current Accounts payable, other, current Firm Owes Facility Expenses The firm owe facility expenses. Disclosure Accrued Expense Additional Information [Abstract] Disclosure - Accrued Expense - Additional Information [Abstract] Accounts Payable and Accrued Liabilities [Table] Accounts Payable and Accrued Liabilities [Table] Board Committee Meeting fee [Member] Board commottee meeeting fee Legal Fee [Member] Legal Fee Legal Fee [Member] Stock Transfer Agent [Member] Stock Transfer fees Stock Transfer Agent [Member] Expenses [Member] Expenses Expenses [Member] Management Incentive Award [Member] Management Bonus Accrual Management Incentive Award [Member] Accounts Payable and Accrued Liabilities [Line Items] Accounts Payable and Accrued Liabilities [Line Items] Accounts Payable and Accrued Liabilities [Line Items] Disclosure Accrued License Payments Related Party Additional Information [Abstract] Disclosure - Accrued License Payments - Related Party - Additional Information [Abstract] Reference Period Disclosure [Axis] Reference Period Disclosure Reference Period Disclosure [Domain] Reference Period Disclosure Previous [Member] Past Patent Expenses Previous [Member] Disclosure Stockholders Equity Additional Information [Abstract] Disclosure - Stockholders' Equity - Additional Information [Abstract] Shareholders Equity [Table] Shareholders Equity [Table] Investor [Member] Investors Placement Agent [Member] Placement Agent Placement Agent [Member] Bio Path Holdings Inc [Member] BioPathHoldingsInc Bio Path Holdings Inc [Member] Ogden Golf Corporation [Member] Ogden Golf Co. Ogden Golf Corporation [Member] Statement Scenario [Axis] Scenario Unspecified [Domain] Equity Unit Purchase Agreements [Member] Equity Unit Purchase Agreements Financing Agreement [Member] LPC financing agreement Financing Agreement [Member] Statement Class Of Stock [Axis] Class Of Stock [Domain] Founders [Member] Founders Founders [Member] Additional Shares [Member] Additional Shares Additional Shares [Member] Due Diligence Efforts [Member] DueDiligenceEfforts Due Diligence Efforts [Member] Lincoln Park Capital Fund Limited Liability Company [Member] LPC Lincoln Park Capital Fund, LLC [Member] Other Ownership Interests By Name [Axis] Other Ownership Interests Name [Domain] Investor Relations Services [Member] Investor Relations Services Investor Relations Services [Member] Presented Scenarios By Scenario [Axis] Presented Scenarios By Scenario [Axis] Presented Scenarios By Scenario [Domain] Presented Scenarios By Scenario [Domain] Scenario One [Member] Scenario 1 Scenario 1 [Member] Scenario Two [Member] Scenario 2 Scenario 2 [Member] Scenario Three [Member] Scenario 3 Scenario 3 [Member] Shareholders Equity [Line Items] Shareholders Equity [Line Items] Shareholders Equity [Line Items] Stock Issued During Period Shares Contingent Considerations Common stock issued , shares Stock Issued During Period Shares Contingent Considerations Stock Issued During Period Shares Merger Common stock issued merger transactions, shares Number of shares of stock issued during the period pursuant to a merger. Stock Retained By Shareholders Shares Merger Transaction Common stock retained shareholders, shares Stock Retained by Shareholders, Shares, Merger Transaction Fair Value Of Common Stock Issued Common stock issued for services, value Fair value of common stock issued. Common Stock Additional Shares Issued Common stock issued, additional shares Common Stock Additional Shares Issued Issuance Of Common Stock Shares For Service Common stock issued for service, shares Issuance Of Common Stock Shares For Service Issuance Of Common Stock and Warrants Shares Common stock and warrant issued, shares Issuance Of Common Stock And Warrants, Shares Common Stock Repurchased Shares Common stock repurchased, shares Common Stock Repurchased Shares Issuance Of Common Stock and Warrants Value Common stock and warrants issued, Value Value of issuance of common stock and warrants. Stock Committed To Be Issued During Period Value Acquisitions Equity purchase agreement value Stock Committed to be Issued During Period, Value, Acquisitions Proceeds From Issuance Of Common Stock Proceeds from issuance of common stock and warrant from LPC Net proceeds from sale of common stock Stock Committed To Be Issued During Period Shares Acquisitions Committed shares issued Stock Committed to be Issued During Period, Shares, Acquisitions Issuance Of Warrants Shares Warrants issued, shares Issuance Of Warrants, Shares Stock Issued During Period Shares Stock Warrants Exercised Common stock issued for exercise of warrant (in shares) Number of shares issued during the period as a result of the exercise of warrants. Stock Issued During Period Value Warrant Exercises Common stock issued for exercise of warrant Stock Issued During Period Value Warrant Exercises Issuance Of Stock and Warrants For Services Or Claims Common stock issued for services Common Stock Shares Issued Common Stock, shares issued Common Stock Shares Outstanding Common Stock, shares outstanding Disclosure Stock Options and Warrants Additional Information [Table] Management [Member] Management Research And Development Activities [Member] R&D Activities Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Share based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value ShareBased Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate Stock or Unit Option Plan Expense Stock option expense Disclosure Commitments and Contingencies Additional Information [Abstract] Disclosure - Commitments and Contingencies - Additional Information [Abstract] Product Liability Contingency [Table] Technology Licenses [Member] Licenses Agreement Technology Licenses [Member] Finite Lived Intangible Assets By Major Class [Axis] Finite Lived Intangible Assets Major Class Name [Domain] Supply Agreement [Member] Supply Agreement Supply Agreement [Member] Patented Technology [Member] Patented Technology Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Event Product Liability Contingency [Line Items] Product Liability Contingency [Line Items] Cost Of Reimbursable Expense Estimates reimbursable past patent expenses Accrued Patent Expense Current Patent expense per quarter Accrued Patent Expense, Current Accounts Payable and Accrued Liabilities Accounts payable and accrued liabilities Accrued Liabilities Related Party Current Accrued expense - related party Accrued Liabilities Related Party Current Drug Product Testing Agreement Consideration To Be Paid In Stages Drug Product Testing Agreement Consideration To Be Paid In Stages Represents consideration to be paid in various stages with respect to agreement with its drug product manufacturer for testing. Preferred Stock Par Or Stated Value Per Share Preferred Stock, par value Preferred Stock Shares Authorized Preferred Stock, shares authorized Preferred Stock Shares Issued Preferred Stock, shares issued Preferred Stock Shares Outstanding Preferred Stock, shares outstanding Common Stock Par Or Stated Value Per Share Common Stock, par value Common Stock Shares Authorized Common Stock, shares authorized Income Statement [Abstract] All Other [Member] All Other All Other [Member] Related Party Transactions [Member] MD Anderson for License Related Party Transactions [Member] Related Party [Member] Related Party RelatedpartyMember Revenues Revenue Operating Expenses [Abstract] Operating expense General and Administrative Expense General & administrative Operating Expenses Total operating expense Operating Income Loss Net operating loss Nonoperating Income Expense [Abstract] Other income (expense) Investment Income Interest Interest income Other Nonoperating Income Other income Other Nonoperating Expense Other expense Nonoperating Income Expense Total Other Income (Expense)